24-25 October, 2020
BIOGNOSYS POSTERS
Biognosys is proud to announce the presentation of two posters at this years’ EORTC-NCI-AACT (ENA) Virtualn Conference:
High-Resolution Limited Proteolysis (HR-LIP): A Novel Approach for Target Validation and Lead Compound Optimization (Abstract)
Y. Feng1, N. Beaton1, J. Adhikari2, R. Bruderer1, R. Tomlinson2, I. Cornella-Taracido2, L. Reiter1.
1) Biognosys AG, Schlieren, Switzerland. 2) Cedilla Therapeutics, Cambridge, USA.
1) Biognosys AG, Schlieren, Switzerland. 2) Cedilla Therapeutics, Cambridge, USA.
LiP-Quant, an Automated Chemoproteomic Approach to Identify Drug Targets in Complex Proteomes (Abstract)
Y. Feng1, N. Beaton1, I. Piazza2, R. Bruderer1, P. Picotti2, L. Reiter1.
1) Biognosys, Schlieren, Switzerland. 2) ETH Zurich, Institute of Molecular Systems Biology, Zurich, Switzerland.
MORE INFORMATION
More information about our Limited Proteolysis (LiP) technology is available here.
More information about our LiP-based Target Deconvolution approach is available here.
Book a meeting with our team to get your personal presentation of our posters!
Request a consultation with our proteomics experts to explore how our proteomics platform can accelerate your research!
